We are live on
!
Find out more
MM
MWG Management Portfolio holdings
AUM
$81.3M
1-Year Est. Return
2.28%
This Fund
S&P 500
This Quarter
Est. Return
-11.86%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
–
AUM
$825M
AUM Growth
-$193M
(-19%)
Cap. Flow
+$58.6M
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RELX
RELX
|
+$96.8M |
| 2 |
Vir Biotechnology
VIR
|
+$3.53M |
| 3 |
Lyell Immunopharma
LYEL
|
+$460K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.94% |
| 2 | Industrials | 22.06% |
Similar funds
BCCM
BPC
AE
BHMP
LMKC
ASM
KDIA
CM
MWG Management's Q3 2021 Portfolio in Review
As of Q3 2021, MWG Management held 5 positions worth $825M, down 19% from $1.02B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MWG Management deployed $58.6M of net new capital in Q3 2021, opening 1 new position. Its largest new stake was Illumina: 346,541 shares worth $137M.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 63% a quarter earlier, followed by Industrials.
On the sell side, the largest reduction was RELX, an estimated $96.8M trimmed.
- MWG Management's largest Q3 2021 buy was Illumina: 346,541 shares worth $137M.
- MWG Management's biggest Q3 2021 reduction was RELX, cutting an estimated $96.8M.
- MWG Management fully exited Vir Biotechnology in Q3 2021, selling an estimated $3.53M.
- MWG Management's ten largest holdings make up 100% of its $825M portfolio in Q3 2021.
- MWG Management opened 1 new position and closed 1 in Q3 2021.
- MWG Management's portfolio value fell 19% quarter-over-quarter to $825M.
Based on MWG Management's 13F filing for Q3 2021, filed 15 Nov 2021.